The objective of the study was to compare follicle growth and pregnancy per artificial insemination (P/AI) in crossbreed heifers receiving either a low dose of hCG (150 IU) or a low dose of FSH (20 mg) vs. a control group during the final stage of a split-AI protocol. A total of 387 heifers were enrolled in the trial and were randomly assigned in three treatments (Control n = 134, FSH n = 125, and hCG n =128) within reproductive tract score (RTS; 1 to 5 scale), body condition score (BCS; 1 to 9 scale) and pubertal status. All groups were synchronized with a 7-day CO-Synch + CIDR protocol, at CIDR removal the two treatments were injected, an Estrotect patch was placed, and the diameter of the dominant follicle was assessed through transrectal ultrasonography, at day 9 heifers that presented estrus (> 50% of the Estrotect patch rubbed off) were AI, and those that did not were TAI at day 10. An ultrasound was carried out along with the AI to measure the diameter of the preovulatory follicle and 30 days after for pregnancy check. The data was analyzed using the GLIMMIX procedure (SAS). The diameter of the preovulatory follicle was different among treatments (Control: 11.48 ± 0.21; FSH: 11.48 ± 0.25; hCG; 10.73 ± 0.28; P = 0.01). However, the rate of follicular growth (Control: 4.96 ± 0.37; FSH: 4.59 ± 0.39; hCG: 5.12 ± 0.38; P = 0.64) and P/AI (control: 41.35%; FSH: 35.77%; and hCG: 34.38%; P = 0.47) were not different among groups. There was a significant difference (P < .0001) in P/AI when comparing animals that presented estrous (48.99%) or not (29.27%). In conclusion, the use of low dosed of hCG or FSH at the time of device removal did not increase the proportion of pregnant heifers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.